57 patients with Adult Respiratory Distress Syndrome (ARDS) requiring Extracorporeal membrane oxygenation (ECMO) therapy were analyzed retrospectively. 28 patients had received immunglobulin M-enriched immunoglobulin therapy (IVIG); 29 patients did not receive IVIG therapy. These patients were analyzed regarding length of stay in intensive care unit (LOS ICU), length of stay (LOS) in hospital and regarding mortality.
57 patients with ARDS requiring ECMO therapy were analyzed retrospectively. 28 patients had received IgM-enriched immunoglobulin therapy (IVIG); 29 patients did not receive IVIG therapy. Patient characteristics, like Acute Physiology And Chronic Health Evaluation (APACHE) and Sepsis-related organ failure assessment (SAPS) Score, preexisting diseases, origin of infection, duration of ECMO therapy were analyzed in these patients. These patients were further analyzed regarding LOS ICU, LOS in hospital and regarding mortality.
Study Type
OBSERVATIONAL
Enrollment
57
Treatment for 3 days
University Hospital Tuebingen
Tübingen, Germany
Mortality
Death during ICU therapy
Time frame: during ICU treatment, up to 28 days
lengh of stay (LOS ICU)
lengh of stay on ICU in days
Time frame: up to 60 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.